This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
News
UK company launches ‘high strength’ non-alcoholic shots with CBD
New UK drinks start-up OTO has expanded its range by selling non-alcoholic shots that contain a “recommended daily dose” of cannabidiol (CBD); the non-psychoactive component of cannabis.
There are three flavours in the new OTO range: ‘Spice’, which the company claims helps to enhance concentration; ‘Zest’, which is advertised as aiding heart health and low blood pressure; and ‘Bloom’, which OTO claims will “support quality sleep and reduced anxiety.”
Each 60ml shot, priced at £6.99, contains 50mg of “high quality CBD”, according to the company, which already sells a range of “high strength” CBD-infused cocktail bitters.
According to figures from the Cannabis Trades Association UK, the number of cannabidiol consumers in the UK doubled from 125,000 in 2017 to 250,000 last year.
The drinks range has been developed by a team of industry leaders including food scientist, Dr. Ketan Joshi; Antonia Jamison, a founding director at Sipsmith Gin, managing director of OTO, Gemma Colao, and James Bagley, CEO of DMD Ventures, which owns drinks retailer 31 Dover.
The CBD for the shots is extracted from organically grown hemp plants, while each flavour is also infused with botanicals selected to “complement the effects of CBD”, such as lemongrass, ginger, cinnamon, tumeric and lavender.
Co-creator, Gemma Colao, said the new RTDs are “a simple and enjoyable way to get the perfect dose of CBD, whether it’s taken as a shot or mixed with a cocktail.”
“We’ve designed three unique blends that perfectly complement our customer’s needs, from improving focus to creating more balance in their everyday lives.”
Joshi said the startup has carried out “extensive research and trials to determine the optimum daily dose of CBD.”
“Our continuing trials with CBD have proven fantastic results, with users experiencing incredible benefits from improved sleep, better concentration and reduced anxiety as a result.
“We are confident our new RTDs will encourage more people to make CBD a simple, yet effective part of their daily routine – and reap the benefits of improved overall health and wellbeing.
The shots are available for both the on and off trade from OTO’s website.